At 500+ P/E and 55.1 forward P/E, the market is pricing CWST as a long-duration growth compounder despite clear evidence of weak underlying profitability. A PEG of 8.8 signals extreme overvaluation relative to growth, and an Altman Z-Score of 2.5 places the company in a gray zone where balance sheet risk is not trivial. With operating margin at just 0.50% and ROIC at 1.40%, this is not a capital-efficient business today. The valuation implies future operational inflection that is nowhere visible in the current return profile, making the stock look aggressively priced relative to its financial resilience.